News

Mirim-Zine

  • 미림진, BIO USA 2023 참가 / MirimGENE, at BIO USA 2023

    June 15, 2023

    MirimGENE attended BIO USA 2023 in Boston from June 5th to 8th and was chosen as the presenting company at BIO USA 2023.MirimGENE was also able to connect with numerous global companies such as Novartis, Merck, Pfizer and present our science and technology to them.   

    READ MORE >
  • 미림진, 중기부 아기유니콘 선정 / MirimGENE, MSS's 'Baby Unicorn' designation

    May 30, 2023

    On Tuesday, May 30, the Ministry of SMEs and Startups selected 51 ‘Baby Giant Startups (Unicorns)’ that have a high potential to grow into global giant startups (Unicorns). MirimGENE is designated as one of the finalist for Ministry of SMEs and Startups' Baby Unicorn.  source : https://mss.go.kr/site/smba/ex/bbs/View.do?cbIdx=86&bcIdx=1042056&parentSeq=1042056&n...

    READ MORE >
  • 미림진, KDRA 바이오 혁신기업 포스터존에 참가 / MirimGENE, Participated in the KDRA Bio innovative companies poster zone.

    May 16, 2023

    MirimGENE participated in KDRA Bio innovative companies poster zone for the promotion of bio-venture, start-ups, universities, and lab's technologies in part of "KOREA PHARM & BIO 2023", the largest domestic pharm·bio-health industry fair and introduced the excellent Rheumatoid Arthritis treatment effect of WARS1 Neutralizing antibody.    

    READ MORE >
  • 미림진, 혁신신약 파이프라인UP 발표 / MirimGENE, Presented at the Acceleration Project in Innovative Drug Development

    April 25, 2023

     The CEO of MirimGENE, Professor Jin, gave a presentation on "Sepsis theranostic innovative drug development" at the Acceleration Project in Innovative Drug Development on April 25th. 

    READ MORE >
  • 미림진, 2023 국가신약개발사업 R&D 워크샵 우수 포스터로 지정 / MirimGENE, Designation of an excellent poster at the 2023 KDDF R&D Workshop

    February 06, 2023

    1Mirim Jin, CEO of MirimGENE, gave a presentation on the topic of Novel antibody candidate for Rheumatoid Arthritis at the 2023 Korea Drug Development Porject Fund (KDDF) R&D Workshop held in Yeoju. Also, on this day, MirimGENE's poster was designated as an excellent poster.  

    READ MORE >
  • 미림진, 세계 최초 바이오마커로 투자자 이목 집중

    December 01, 2022

      source : 세계 최초 바이오마커-CJ도 반한 배지기술에 쏠린 투심 - 팜이데일리 (edaily.co.kr)  

    READ MORE >